Organogenesis Holdings Inc (ORGO)
2.345
+0.06
(+2.63%)
USD |
NASDAQ |
Apr 26, 16:00
2.345
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Price to Book Value: 1.111 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.082 |
| April 24, 2024 | 1.411 |
| April 23, 2024 | 1.411 |
| April 22, 2024 | 1.406 |
| April 19, 2024 | 1.373 |
| April 18, 2024 | 1.354 |
| April 17, 2024 | 1.321 |
| April 16, 2024 | 1.354 |
| April 15, 2024 | 1.307 |
| April 12, 2024 | 1.364 |
| April 11, 2024 | 1.421 |
| April 10, 2024 | 1.397 |
| April 09, 2024 | 1.383 |
| April 08, 2024 | 1.406 |
| April 05, 2024 | 1.340 |
| April 04, 2024 | 1.326 |
| April 03, 2024 | 1.312 |
| April 02, 2024 | 1.236 |
| April 01, 2024 | 1.326 |
| March 28, 2024 | 1.345 |
| March 27, 2024 | 1.307 |
| March 26, 2024 | 1.241 |
| March 25, 2024 | 1.241 |
| March 22, 2024 | 1.236 |
| March 21, 2024 | 1.260 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.326 |
| March 19, 2024 | 1.302 |
| March 18, 2024 | 1.302 |
| March 15, 2024 | 1.350 |
| March 14, 2024 | 1.345 |
| March 13, 2024 | 1.421 |
| March 12, 2024 | 1.392 |
| March 11, 2024 | 1.411 |
| March 08, 2024 | 1.473 |
| March 07, 2024 | 1.482 |
| March 06, 2024 | 1.350 |
| March 05, 2024 | 1.316 |
| March 04, 2024 | 1.364 |
| March 01, 2024 | 1.383 |
| February 29, 2024 | 1.691 |
| February 28, 2024 | 1.653 |
| February 27, 2024 | 1.695 |
| February 26, 2024 | 1.653 |
| February 23, 2024 | 1.630 |
| February 22, 2024 | 1.598 |
| February 21, 2024 | 1.616 |
| February 20, 2024 | 1.612 |
| February 16, 2024 | 1.640 |
| February 15, 2024 | 1.734 |
| February 14, 2024 | 1.732 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9332
Minimum
Mar 24 2023
59.99
Maximum
Nov 13 2019
9.387
Average
6.601
Median
Nov 06 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.723 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6668 |
| Theriva Biologics Inc | 0.1948 |
| Oragenics Inc | 2.986 |
Price to Book Value Related Metrics
| PE Ratio | 65.76 |
| PS Ratio | 0.7176 |
| Price to Free Cash Flow | 47.43 |
| Price | 2.345 |
| Earnings Yield | 1.52% |
| Market Cap | 309.45M |
| Operating PE Ratio | 24.82 |
| Normalized PE Ratio | 65.76 |